This inventor holds 3 USPTO granted patents. Top assignees: Cornell University, Sloan-Kettering Institute for Cancer Research, Rutgers, The State University of New Jersey. Active years: 2003-2015.
Company Filing History:
2 out of 2,948 
2 out of 518 
1 out of 1,494 
Years Active: 2003-2015
Title: Innovations and Contributions of Inventor Philip Paty
Introduction
Philip Paty is a notable inventor based in New York, NY, who has made significant contributions to the field of cancer research. With a total of three patents to his name, his work focuses on innovative methods for evaluating cancer states and genomic mapping.
Latest Patents
One of Philip Paty's latest patents is titled "Use of lecithin:retinol acyl transferase gene promoter methylation in evaluating the cancer state of subject." This invention relates to a method of assessing the cancer state of a subject by analyzing the methylation status of the LRAT gene promoter. It also includes methods for determining prognosis by evaluating LRAT mRNA and protein expression. Another significant patent is "Accelerating identification of single nucleotide polymorphisms and alignment of clones in genomic sequencing." This invention provides a method for assembling genomic maps of an organism's DNA, allowing for the identification and quantification of single nucleotide polymorphisms through advanced genomic techniques.
Career Highlights
Throughout his career, Philip Paty has worked with esteemed organizations such as the Cornell Research Foundation Inc. and the Sloan Kettering Institute for Cancer Research. His work in these institutions has contributed to advancements in cancer detection and treatment methodologies.
Collaborations
Philip has collaborated with notable colleagues, including Francis Barany and Brian W. Kirk, enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Philip Paty is a distinguished inventor whose innovative patents and career achievements have significantly advanced the field of cancer research. His contributions continue to influence the development of new diagnostic and treatment methods.